Navigation Links
Update on velaglucerase alfa
Date:9/8/2009

CAMBRIDGE, Massachusetts, September 8 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, is committed to doing everything possible to assist Gaucher patients and their physicians during the imiglucerase supply shortage. Shire is pleased to be able to provide velaglucerase alfa well over a year ahead of previously anticipated commercial launch world wide.

In the U.S., the velaglucerase alfa treatment protocol is currently open and enrolling patients. In the EU and other regions, Shire is engaging with national and regional authorities to seek pre-approval access using the fastest mechanisms available in each region. Shire will manage, on an ongoing basis, the overall global supply of velaglucerase alfa based on the evolving need as communicated to us by physicians.

Shire has accelerated its manufacturing timeline by almost 18 months in order to provide velaglucerase alfa for the long-term treatment of Gaucher patients during 2009 and beyond. Shire currently has supply of velaglucerase alfa for several hundred patients world-wide. The total number of patients Shire can treat is dependent on the patient weight, as well as the administered dose as recommended by their treating physician; Shire estimates this could translate into a range of 300 to 600 patients for uninterrupted treatment starting in September 2009. Shire also expects that several hundred more patients can be added throughout 2010; the range will again depend on patient weight, and doses.

Shire is working with a global group of experienced Gaucher physicians to ensure that physicians put in place guidelines that consider patients in the greatest need of treatment during the supply crisis. Individual treatment decisions will remain with the patient's
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
2. ThromboGenics NV Announces Business Update and Half Year Results 2009
3. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
4. ThermoGenesis Provides Update on Fiscal 2009 Results
5. ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
6. GeoVax Labs, Inc. Provides Clinical Studies Update
7. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
8. SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
9. Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
10. Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
11. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Springs, FL (PRWEB) December 18, 2014 ... of the nation’s leading specialty pharmacies, has an ... serve as clinical pharmacy consultants for prescriber offices ... therapy expertise. , “We have a variety ... therapies. For example, those specializing in hepatitis C ...
(Date:12/19/2014)... 18, 2014 Ed Bilsky, Ph.D., vice ... Center for Excellence in the Neurosciences (CEN), and professor ... been selected as a member of the prestigious Dana ... neuroscientist from Maine to receive this honor. , ... entirely by the Dana Foundation. Its mission is ...
(Date:12/19/2014)... contrast to traditional LED lights where the spectrum is ... LED technology to incorporate their spectra in a single ... in low proximity installations. The Valoya L-series offers high ... is up to four times longer than commonly used ... clearly higher when compared to traditional fluorescent or LED ...
(Date:12/19/2014)... 18, 2014  Decision Resources Group finds that the ... will grow moderately through 2023 as the aging population, ... of dental biomaterials all spur procedure volumes. Growth will ... China and India ... within reach for a larger proportion of the population. ...
Breaking Biology Technology:BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3
... (Nasdaq: RDEA ) today announced the formation ... SAB will provide independent,scientific advice and counsel to ... and development of drugs to treat chronic,inflammatory diseases, ... have brought together a group of international authorities ...
... Pharmaceuticals,Inc. (NYSE: BRL ) today confirmed that ... of the patents listed by GlaxoSmithKline in,connection with ... believes that it is the first to file ... IV certification for Avodart., Barr filed its ...
... /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), a biotechnology ... therapeutics, today announced that five abstracts have been,selected ... Research,(AACR) Annual Meeting held from April 12-16, 2008 ... that will disclose new findings,about its CD44, TROP-2, ...
Cached Biology Technology:Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3Barr Confirms Patent Challenge of Avodart(R) Soft Gelatin Capsules, 0.5mg 2Barr Confirms Patent Challenge of Avodart(R) Soft Gelatin Capsules, 0.5mg 3ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting 2ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting 3
(Date:12/10/2014)... Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ... the ultimate driver in long-term mass consumer adoption of ...
(Date:12/5/2014)... , Dec. 4, 2014 Increased ... boosted investments in new testing and inspection technologies. ... given rise to a range of innovative test ... requirements of Generation Y, which is generally more ... a result, product development strategies of test equipment ...
(Date:11/21/2014)... 18, 2014 According to a ... Systems (Video, RFID, Access Control, Intrusion Detection, Parking Management, ... Government), Component Service Geography - Global Forecasts to 2020", ... projected to be around $25 Billion in 2014 and ... at a CAGR of 8.69%. Browse 116 ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... in Spanish . , In future, climate change ... in the concentration of CO 2 in the atmosphere. However, ... physiology of barley plants and increases its tolerance to salinity. This ... defended at the University of the Basque Country (UPV/EHU). Barley ...
... Early laboratory research has shown that resveratrol, a common ... most types of breast cancer, suggesting a potential role for ... substance found in red wine and red grapes. It is ... major drug stores. "Resveratrol has the ability to ...
... Men who develop breast cancer are often not treated ... treatment becomes difficult, new results show. Although most ... 1% of cases, Dr. Marina Garassino from the Orion ... organized by the European Society for Medical Oncology. ...
Cached Biology News:CO2 increase in the atmosphere augments tolerance of barley to salinity 2CO2 increase in the atmosphere augments tolerance of barley to salinity 3CO2 increase in the atmosphere augments tolerance of barley to salinity 4Researchers identify cancer preventive properties in common vitamin supplement 2Treatment delays result in poor outcomes for men with breast cancer 2
... The Bio-Plex maintenance, calibration, ... a custom 96-well plate used ... and calibration procedures using the ... MCV plate is for use ...
A flexible 24-48 hour DNA sequencing service. Samples may be shipped in standard 1.5mL tubes. Oligo synthesis and DNA preparation available. Read lengths up to 850 Phred 20 bases. Universal primers p...
... Agencourts cDNA sequencing and finishing ... needs. Agencourt can perform large-scale 5' ... and finishing. Our considerable experience with ... programs make Agencourt an ideal cDNA ...
... turnaround sequencing of individual research samples, including ... plasmids. Agencourt's world-class, high performance sequencing pipeline ... day. The key benefits of Agencourt's ... 48 hour sample turnaround, industry leading ...
Biology Products: